Tarsus Pharmaceuticals, Inc. financial data

Symbol
TARS on Nasdaq
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 23 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 461% % -22%
Quick Ratio 3.4% % -29%
Debt-to-equity 55% % 10%
Return On Equity -20% % 58%
Return On Assets -13% % 59%
Operating Margin -16% % 76%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42,557,492 shares 1.3%
Common Stock, Shares, Outstanding 42,553,931 shares 11%
Entity Public Float $1,700,000,000 USD 71%
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 41,784,014 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 41,784,014 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $451,360,000 USD 147%
Research and Development Expense $64,322,000 USD 20%
General and Administrative Expense $57,910,000 USD 91%
Costs and Expenses $522,329,000 USD 72%
Operating Income (Loss) $70,969,000 USD 41%
Nonoperating Income (Expense) $6,610,000 USD 32%
Net Income (Loss) Attributable to Parent $66,418,000 USD 43%
Earnings Per Share, Basic -1.59 USD/shares 48%
Earnings Per Share, Diluted -1.59 USD/shares 48%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $183,640,000 USD 94%
Marketable Securities, Current $233,627,000 USD 19%
Accounts Receivable, after Allowance for Credit Loss, Current $85,057,000 USD 82%
Inventory, Net $4,372,000 USD 67%
Assets, Current $522,782,000 USD 47%
Property, Plant and Equipment, Net $11,665,000 USD 404%
Operating Lease, Right-of-Use Asset $10,080,000 USD 1726%
Intangible Assets, Net (Excluding Goodwill) $7,366,000 USD -12%
Other Assets, Noncurrent $1,861,000 USD 86%
Assets $562,158,000 USD 49%
Accounts Payable, Current $16,387,000 USD 74%
Employee-related Liabilities, Current $17,779,000 USD 12%
Liabilities, Current $135,695,000 USD 68%
Operating Lease, Liability, Noncurrent $10,599,000 USD
Other Liabilities, Noncurrent $10,599,000 USD
Liabilities $218,732,000 USD 43%
Accumulated Other Comprehensive Income (Loss), Net of Tax $381,000 USD 113%
Retained Earnings (Accumulated Deficit) $426,628,000 USD -18%
Stockholders' Equity Attributable to Parent $343,426,000 USD 53%
Liabilities and Equity $562,158,000 USD 49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,651,000 USD 45%
Net Cash Provided by (Used in) Financing Activities $136,562,000 USD 26%
Net Cash Provided by (Used in) Investing Activities $34,942,000 USD 66%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 42,553,931 shares 11%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $80,969,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $186,203,000 USD 91%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,074,000 USD 139%
Deferred Tax Assets, Valuation Allowance $107,935,000 USD 23%
Deferred Tax Assets, Gross $112,673,000 USD 27%
Operating Lease, Liability $10,599,000 USD 1643%
Depreciation $855,000 USD 25%
Payments to Acquire Property, Plant, and Equipment $590,000 USD 239%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $66,216,000 USD 43%
Lessee, Operating Lease, Liability, to be Paid $28,398,000 USD 3450%
Property, Plant and Equipment, Gross $13,763,000 USD 221%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,625,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $2,021,000 USD 153%
Operating Lease, Weighted Average Discount Rate, Percent 0.114 pure 3.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,956,000 USD 39753%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,704,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $41,461,000 USD 23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $4,279,000 USD -9.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,783,000 USD
Operating Lease, Payments $858,000 USD 7.4%
Additional Paid in Capital $769,667,000 USD 32%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $961,000 USD 78%
Deferred Tax Assets, Net of Valuation Allowance $4,738,000 USD 1238%
Share-based Payment Arrangement, Expense $41,720,000 USD 50%
Interest Expense $3,645,000 USD 42%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%